CYBB and Myocardial fibrosis: These effects seem to be related to improvement of high glucose-induced cardiac dysfunction, myocardial fibrosis, cell death and oxidase stress, resulting from suppressing the activation of gp91phox isoform and correcting the myocardial imbalance of oxidant and antioxidant (Figure 7).